Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

Starting soon

Conditions studied: IgA Nephropathy (IgAN)

In brief

An observational study tracking the clinical course of patients with IgA nephropathy.

Key facts

Study ID

NCT07555301

Run by

Waid City Hospital, Zurich

People needed

50

Starts

2026-06-01

Expected to finish

2029-12-31

Last updated by the study team

2026-04-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• IgA Nephropathy, Use of Sparsentan

You may not qualify if…

• age < 18y

Where it is running

• Stadtspital Zurich — Zurich, Canton of Zurich, Switzerland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.